4

OWNERSHIP DOCUMENT

Company: Tonix Pharmaceuticals Holding Corp.
Filed: June 21, 2016
Period of Report: June 21, 2016
Accession Number: 0001615774-16-005998

View Document ↗ View on SEC.gov ↗